Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 9, Issue 2
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
PDF +
Supplementary
Material
XML
Clinical/translational cancer immunotherapy
Original research
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors
Online download statistics by month:
Online download statistics by month: February 2021 to February 2024
Abstract
Full
Pdf
Feb 2021
678
678
262
Mar 2021
427
427
192
Apr 2021
217
218
144
May 2021
215
215
123
Jun 2021
196
196
90
Jul 2021
171
171
77
Aug 2021
164
164
72
Sep 2021
165
165
88
Oct 2021
185
185
82
Nov 2021
197
197
97
Dec 2021
164
164
58
Jan 2022
145
156
72
Feb 2022
160
178
129
Mar 2022
207
212
135
Apr 2022
155
159
104
May 2022
197
201
130
Jun 2022
152
157
92
Jul 2022
171
177
95
Aug 2022
217
223
136
Sep 2022
180
181
152
Oct 2022
216
218
144
Nov 2022
196
200
101
Dec 2022
139
139
81
Jan 2023
166
166
134
Feb 2023
195
195
116
Mar 2023
182
185
148
Apr 2023
188
188
93
May 2023
138
138
91
Jun 2023
102
102
72
Jul 2023
161
163
107
Aug 2023
121
121
64
Sep 2023
80
80
43
Oct 2023
134
135
80
Nov 2023
258
261
69
Dec 2023
221
222
49
Jan 2024
110
112
70
Feb 2024
92
92
59
Total
7062
7141
3851
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?